Author Archive: Abigail Hirsch

Abigail was the Director of Events Communications at BIO.

Latest Posts

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home


And of those 39 US-based biotech companies, five of them are from San Diego, highlighting the region’s growing importance as hub for the biotech and life science industries. According to a recently authored BIO article in the Union Tribune San Diego, there are several reasons at play for the strong public offerings – enactment of the JOBS Act, an eager investor market and increasing regulatory transparency resulting from PDUFA V. As powerful as the JOBS Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Bioscience’s Bright Spots


According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO agrees. “In the past several years, it has become more important than ever for those in our industry to form partnerships and collaborations,” says Fritz Bittenbender, executive vice president, external affairs, BIO. “Big pharma, small biotechs, universities, investors, patient groups, the NIH – everyone is recognizing that success is only achieved by working with others. One place we’ve seen this Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Couldn’t Make it to San Francisco This Week?


Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare Conference. Before arriving, hopefully you read the survival guide put forth by the InVivo blog team. In it, Chris Morrison and team outlined a few helpful talking points to help you when running in to industry colleagues. Likewise, Luke Timmerman, from Xconomy, has all the industry news you need to know heading in to the event, perhaps most importantly; who he thinks should Read More >

Business and Investments, Events  |  1 Comment  |  Email This Post
Tags: , , , , ,

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry


Innovative biotech companies at all stages of the development process are working toward next generation technologies to heal, fuel, and feed the world. In an effort to highlight promising policy legislation and its impact on the biotech sector, BIO has authored the following white paper: The Future Policy Landscape for Emerging Biotechnology Companies. Many research-intensive companies rely on private investment to support their groundbreaking R&D. Therefore, favorable legislation such as the JOBS Act is essential Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Value of Partnering Continues to be a Draw for BIO Events

Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia. These meetings allowed industry executives to meet and explore business opportunities with China’s emerging biotech sector. One company in particular, SciClone Pharmaceuticals, invited BioWorld to tag along for the day and get an insider’s look at what a full day of partnering entails. To better understand the full scope of participating in these partnering meetings, read Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,